Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
June 03 2022 - 06:05AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE
COMMISSION
Washington, D.C.
20549
Form 6-K
Report of Foreign
Private Issuer
Pursuant to Rule 13a-16
or 15d-16
under the Securities
Exchange Act of 1934
For the month of
June, 2022
Commission File Number:
001-41106
Incannex Healthcare
Limited
(Exact name
of Registrant as specified in its charter)
not applicable
(Translation
of Registrant’s name into English)
Australia
(Jurisdiction
of incorporation or organization)
Joel Latham
Chief Executive Officer
and Managing Director
Level 39, Rialto
South Tower
525 Collins Street
Melbourne 3000
Australia
(Address of principal
executive offices)
Indicate by check mark whether the registrant
files or will file annual reports under cover Form 20-F or Form 40-F:
Form 20-F ☒
Form 40-F ☐
Indicate by check mark if the registrant
is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
Yes ☐ No ☒
Indicate by check mark if the registrant
is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):
Yes ☐ No ☒
INFORMATION CONTAINED
IN THIS REPORT ON FORM 6-K
On June 03, 2022, Incannex
Healthcare Limited filed with the Australian Securities Exchange an announcement captioned “Positive final results from IHL-42X
phase 2 trial”, a copy of which announcement is attached to this Form 6-K as Exhibit 99.1.
On June 03, 2022, Incannex
Healthcare Limited filed with the Australian Securities Exchange an announcement captioned “IHL-42X phase 2 clinical trial presentation”,
a copy of which announcement is attached to this Form 6-K as Exhibit 99.2.
Signatures
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.
|
Incannex
Healthcare Limited |
|
|
|
Date:
June 03, 2022 |
By:
|
/s/
Joel Latham |
|
Name: |
Joel
Latham |
|
Title: |
Chief
Executive Officer and Managing Director |
INDEX TO EXHIBITS
3
Incannex Healthcare (NASDAQ:IXHL)
Historical Stock Chart
From Feb 2024 to Mar 2024
Incannex Healthcare (NASDAQ:IXHL)
Historical Stock Chart
From Mar 2023 to Mar 2024